any hot stock suggestions going forward?

[D'Lo Brown]

Without looking too far into this stock, I'd personally be concerned to make a true investment in it. But then again, I'd be pretty concerned to do so with any small pharmaceutical company with investigational drug(s) only. They're gone at the first sign of any bad news, making it a dramatic boom/bust stock, and you will not be the first to know that bad news is coming. Speculative traders lose a ton of money on these kinds of companies.

That said, no harm at all in putting a lose-able amount on it (akin to a bet). I partake in that kind of fun using my Robinhood account all the time.

Also: from a quick glance at the chart, I'd say wait at least a couple days to see if it goes down any further, especially if it goes down past 29.75.

Anyways, there are probably actual professionals on this board that would give better advice!

Edit: actually it looks like they do have a couple money-making drugs, but of course, the company is losing a fortune yearly, as it is. The gist of what I said is still true since the hopes of the company rest in a single investigational drug - the stock will plummet with any bad news.

[GooooMarquette]

Cryptocurrencies seem to be a steal right now....

[Tortuga94]

One of my hobbies is researching and investing in the biotech space. I do focus mostly on the oncology space but do look at other areas as well.

Heron Therapeutics is an interesting company, but their success really hinges on HTX-011. Their other drugs are not really taking hold with drs and haven't produced a whole lot of revenue at this point. They want their shareholders to approve a new issue of I believe 50 million shares which will dilute existing shareholders. Of course the plan would be to raise cash for the HTX-011 drug trials. The need for non-opioid options is huge and it could be a blockbuster drug for them.

Keep in mind that they are not the only ones working on that particular issue. Pacira Pharmaceuticals already has a non-opioid alternative that is approved by the FDA for post surgical pain relief. They also have a partnership with JNJ too to market their drug delivery system(Exparel). However, it may be that HTX-011 works better and can get the lion's share of the market. Either way I think the market is large enough for more than just one company to do well.

Full disclosure here, I own Pacira in my personal stock account.

[rocket surgeon]

Full disclosure here, I own Pacira in my personal stock account.

 holy schnikees turtle-that was a $120/sh stock back in 2015!

[Tortuga94]

holy schnikees turtle-that was a $120/sh stock back in 2015!

Yeah, it got clobbered in 2015. After Exparel was approved the stock took off to levels that were way too high. They had some issues with the FDA regarding label expansion and issues with their marketing practices. I had my eye on it back then but never bought any as it was climbing to levels that I knew were unsustainable.

I bought it at a much lower price at the end of last year (31.30/share).
That's why I tell everyone to be very careful when investing in biotech, especially if they are looking at companies that don't have any approved drugs. While I'm comfortable with the risks associated with it, it is the one sector where you better do your due diligence and have an iron stomach. For my clients, I've had them invested in the XBI since 2011. That's been a great investment for us.

I've had alot of good luck with biotechs, but I've taken some lumps too.
Biotechs and pharma cos I have lost money on(AXON, GILD - I still own, DNDN, SRPT(Sarepta)-sold too soon, GSK).

[Jay Bee]

Tort do you recommend Pacira now? ($38.50)

[muwarrior69]

FOX!

[Tortuga94]

Tort do you recommend Pacira now? ($38.50)

It does have a lot of good momentum right now. They were given FDA approval to use Exparel for patients undergoing upper extremity surgery, such as rotator cuff repairs and total shoulder arthroplasty back in April. I think the price should continue to go higher from here but if earnings or guidance disappoint on their next earnings conference call it will likely get whacked.


But as I mentioned earlier, I usually avoid making recommendations on individual biotech companies. If biotech investing interests you, buy the XBI or the IBB. Those are both solid etfs, the XBI invests in smaller firms and more of a managed approach, the IBB gets you the universe of biotech as it mirrors the Nasdaq Biotechnology Index.

[Tortuga94]

FOX!

It looks like the market believes Comcast and Disney will get into a bidding war and one of them will overpay.
 

[rocket surgeon]

I still have no idea how Theranos isn't the biggest story/scandal of 2018 so far. People have literally died as a result of Theranos lies and corporate mismanagement. IMO it is a bigger scandal than the Cambridge Analytica story, and yet relative crickets.

maybe the party is over??

 https://finance.yahoo.com/news/theranos-founder-elizabeth-holmes-steps-down-ceo-205207698.html?soc_trk=gcm&soc_src=338950e1-cae3-359e-bfa3-af403b69d694&.tsrc=notification-brknews

[Warriors, Come Out and Playeeyay]

2 Months Ago : Nintendo 
Today : Nintendo